Skip to main content

Centene Corporation guidance

  • CNC · NYSE
  • Insurance
  • Managed Health Care
  • S&P 500
$74.77+4.91%Close 16 Nov 2026 · Market value $36.19B

In its results release of 27 Oct 2026 (Q3 FY2026), Centene Corporation gave 2 forecasts in figures, among them EPS (gaap) of at least $3.46 for FY2026.

Read from the company's earnings releases and outlook updates of the last two years. Each forecast is shown with the sentence or table row it was read from; what a release does not state in figures is not shown.

Latest guidance given with Q3 FY2026 results, 27 Oct 2026

MeasurePeriodGuidanceAs stated
EPS · GAAP · RaisedFY2026At least $3.46-- Increases 2026 GAAP Diluted EPS Guidance: Greater than $3.46 & Adjusted Diluted EPS Greater than $5.20 --
EPS · AdjustedFY2026At least $5.20-- Increases 2026 GAAP Diluted EPS Guidance: Greater than $3.46 & Adjusted Diluted EPS Greater than $5.20 --

Source: the company's earnings release.

Guidance against results above 1 · within 1 · below 0

The last range given before each period closed, how it moved between releases, and the figure then filed. A measure the company defines itself, or one not comparable with the filed figure, has no verdict.

MeasurePeriodLast guidanceRevisionsDeliveredResult
EPS · AdjustedFY2026At least $5.20Raised 3 times—To come
EPS · GAAPFY2026At least $3.46Raised 3 times—To come
RevenueFY2025$166.5B to $169.5BGiven once$194.8BAbove the range
EPS · GAAPFY2024At least $5.92Given once$6.31Within the range

CNC in the terminal

Guidance said on earnings calls, every revision charted, and guidance set against the analysts' consensus.